InfuSystem Holdings Inc
AMEX:INFU
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Walmart Inc
NYSE:WMT
|
Retail
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
5.8
9.51
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
UnitedHealth Group Inc
NYSE:UNH
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Walmart Inc
NYSE:WMT
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one INFU stock under the Base Case scenario is 10.8 USD. Compared to the current market price of 8.86 USD, InfuSystem Holdings Inc is Undervalued by 18%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
InfuSystem Holdings Inc
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for INFU cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
InfuSystem Holdings Inc
Balance Sheet Decomposition
InfuSystem Holdings Inc
Current Assets | 33.6m |
Cash & Short-Term Investments | 380k |
Receivables | 22.8m |
Other Current Assets | 10.5m |
Non-Current Assets | 71.7m |
PP&E | 51.3m |
Intangibles | 10.4m |
Other Non-Current Assets | 9.9m |
Current Liabilities | 16.9m |
Accounts Payable | 8.9m |
Other Current Liabilities | 8m |
Non-Current Liabilities | 32.9m |
Long-Term Debt | 28m |
Other Non-Current Liabilities | 4.9m |
Earnings Waterfall
InfuSystem Holdings Inc
Revenue
|
132.8m
USD
|
Cost of Revenue
|
-65.7m
USD
|
Gross Profit
|
67.1m
USD
|
Operating Expenses
|
-61.5m
USD
|
Operating Income
|
5.5m
USD
|
Other Expenses
|
-4m
USD
|
Net Income
|
1.5m
USD
|
Free Cash Flow Analysis
InfuSystem Holdings Inc
USD | |
Free Cash Flow | USD |
INFU Profitability Score
Profitability Due Diligence
InfuSystem Holdings Inc's profitability score is 45/100. The higher the profitability score, the more profitable the company is.
Score
InfuSystem Holdings Inc's profitability score is 45/100. The higher the profitability score, the more profitable the company is.
INFU Solvency Score
Solvency Due Diligence
InfuSystem Holdings Inc's solvency score is 51/100. The higher the solvency score, the more solvent the company is.
Score
InfuSystem Holdings Inc's solvency score is 51/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
INFU Price Targets Summary
InfuSystem Holdings Inc
According to Wall Street analysts, the average 1-year price target for INFU is 14.41 USD with a low forecast of 12.63 USD and a high forecast of 15.75 USD.
Dividends
Current shareholder yield for INFU is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Ownership
INFU Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
InfuSystem Holdings, Inc. engages in the provision of healthcare services. The company is headquartered in Rochester Hills, Michigan and currently employs 420 full-time employees. The company went IPO on 2006-06-15. The Company’s segments include Integrated Therapy Services (ITS) and Durable Medical Equipment Services (DME Services). The Company’s core service within its ITS segment is its Oncology Business. The ITS segment supplies electronic ambulatory infusion pumps and associated disposable supply kits to private oncology clinics, infusion clinics and hospital outpatient oncology clinics to be utilized in the treatment of a variety of cancers, including colorectal cancer and other disease states. Its DME Services segments core service is to sell or rent new and pre-owned pole-mounted and ambulatory infusion pumps and other Durable Medical Equipment; sell treatment-related consumables; and provide biomedical recertification, maintenance and repair services for oncology practices as well as other healthcare site settings.
Contact
IPO
Employees
Officers
The intrinsic value of one INFU stock under the Base Case scenario is 10.8 USD.
Compared to the current market price of 8.86 USD, InfuSystem Holdings Inc is Undervalued by 18%.